ZEST BLOG
Science-backed insights, actionable tips, and fresh ideas on optimizing sleep, energy, and performance
Stay up to date with the latest

Orexin Receptor Antagonists (DORAs): Belsomra vs Dayvigo vs Quviviq
What orexin receptor antagonists are, how the three FDA-approved DORAs (Belsomra, Dayvigo, Quviviq) compare, what the research shows, side effects, and how they differ from Ambien-type pills.
11/18/2026

Ramelteon (Rozerem): How It Works, Dosage, Side Effects and vs. Melatonin
Ramelteon (Rozerem) is a prescription melatonin receptor agonist approved for trouble falling asleep, and it is not a controlled substance. Here is how it works, how it is taken, what the trials found, its side effects, and how it compares with melatonin.
11/18/2026

Doxepin for Sleep (Silenor): How Low-Dose Doxepin Works, Dosage and Side Effects
Low-dose doxepin (Silenor 3 mg and 6 mg) is FDA-approved for insomnia with trouble staying asleep, at a fraction of the antidepressant dose. Here is how it works, how it is taken, what the trials found, its side effects, and how it compares with trazodone.
11/18/2026

Trazodone for Sleep: Off-Label Use, Dosage, Side Effects and Risks
Trazodone is FDA-approved only for depression, so using it for sleep is off-label. Here is what the label says, what the insomnia research and the AASM guideline found, its side effects and boxed warning, and how it compares with Ambien.
11/18/2026

Diphenhydramine for Sleep (ZzzQuil, Unisom, Benadryl): Risks and Why Experts Advise Against It
Diphenhydramine (ZzzQuil, Benadryl) and doxylamine (Unisom SleepTabs) are OTC antihistamine sleep aids. Here is what their labels say, Unisom vs. ZzzQuil, why tolerance builds within days, and why sleep and geriatric guidelines advise against them for chronic insomnia and older adults.
11/18/2026

Benzodiazepines for Sleep: Side Effects, Risks and Why Guidelines Urge Caution
Temazepam (Restoril) and four other benzodiazepines are FDA-approved for short-term insomnia. Here is what the label says about dosing and side effects, why the FDA added a boxed warning in 2020, why the Beers Criteria advise older adults to avoid them, and what to discuss with a clinician instead.
11/18/2026

Lunesta (Eszopiclone): Side Effects, Risks and Why Doctors Limit It
Eszopiclone (Lunesta) is approved for insomnia. Here is what the FDA label says about dosing and side effects, including its unpleasant taste, why the FDA added a boxed warning in 2019 and lowered the starting dose in 2014, and why the Beers Criteria advise older adults to avoid it.
11/18/2026

Ambien (Zolpidem): Side Effects, Risks and Why Doctors Limit It
Ambien (zolpidem) is approved for short-term insomnia. Here is what the FDA label says about dosing and side effects, why the FDA added a boxed warning in 2019 and lowered the dose for women in 2013, why the Beers Criteria advise older adults to avoid it, and what to discuss with a clinician.
11/18/2026

Prescription Sleep Medications: A Class-by-Class Guide to Insomnia Drugs and Their Risks
Insomnia medications come in several classes that work differently and carry different risks. This guide compares DORAs, Z-drugs, benzodiazepines, ramelteon, low-dose doxepin, off-label trazodone and OTC antihistamines, with the FDA boxed warnings, Beers Criteria and what the AASM recommends.
11/18/2026

Dayvigo (Lemborexant): How It Works, Dosage and Side Effects
How Dayvigo (lemborexant) works, how it's taken, what the SUNRISE trials found, its side effects, and how it compares with Belsomra, Quviviq and Ambien.
11/18/2026

Belsomra (Suvorexant): How It Works, Dosage and Side Effects
How Belsomra (suvorexant) works, how it's taken, what the trials found, its side effects, and how it compares with Ambien, Dayvigo and Quviviq.
11/18/2026

Quviviq (Daridorexant): How It Works, Dosage, Side Effects and Results
Daridorexant (Quviviq) is the newest dual orexin receptor antagonist (DORA) for insomnia. Here is how DORAs work, how they compare to Ambien and other sleep aids, and how to get a prescription.
8/7/2026